Botanical species · safety record

Combretum micranthum

The EFSA Compendium of Botanicals holds 8 constituent measurements for Combretum micranthum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Combretum micranthum G.Don.

8Constituent measurements

0Safety records

3Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	Solvent extraction	—	Unspecified	Resolve DOI
Cardiac glycosides	Leaves	Solvent extraction	—	Unspecified	Resolve DOI
Saponins	Leaves	Solvent extraction	—	Unspecified	Resolve DOI
Tannins	Leaves	Solvent extraction	—	Unspecified	Resolve DOI
Alkaloids	Leaves	Solvent extraction	—	IR and Raman Spectroscopy	No resolvable identifier
Gallic acid	Leaves	—	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Tannins	Leaves	—	≥ 12 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Tannins	Leaves	—	≤ 14 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

OGAN, AU. ALKALOIDS IN LEAVES OF COMBRETUM-MICRANTHUM - STUDIES ON WEST-AFRICAN MEDICINAL-PLANTS .7. . Planta medica, 1972, vol. 21, no. 2, p. 210-&.
Chika, Aminu., Bello, Shaibu Oricha. Antihyperglycaemic activity of aqueous leaf extract of Combretum micranthum (Combretaceae) in normal and alloxan-induced diabetic rats . Journal of ethnopharmacology, 2010, vol. 129, no. 1, p. 34-37. DOI
Spiegel, K. Jentzsch, P., Fuchs, L. The constituents of the leaves of Combretum micranthum. Planta medica, 1962, vol. 10, p. 1-8.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature